HRSA-23-027: Fiscal Year 2023 Quality Improvement Fund – Maternal Health (QIF-MH)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2022.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make about 12 awards worth $25.0 million in total. Applications closed on December 5, 2022.
From the official notice on Grants.gov, last changed October 4, 2022. Checked November 7, 2026.
- Total funding$25.0 million
- Expected awards12
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | October 4, 2022 |
|---|---|
| Deadline | December 5, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Your organization must be a Health Center Program award recipient with an active H80 grant award to apply.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity for current Health Center Program award recipients to apply for funding under the fiscal year (FY) 2023 Quality Improvement Fund – Maternal Health (QIF-MH). The purpose of QIF-MH funding is to improve maternal health and reduce racial and ethnic maternal health disparities by supporting health centers to partner with patients and the community to develop and pilot innovative, patient-centered, scalable models of care delivery that address the clinical and health-related social needs of health center patients at highest risk of maternal morbidity and mortality. For more details, see Program Requirements and Expectations.
Who has won Grants for New and Expanded Services under the Health Center Program grants before
From fiscal 2021 to 2025, Grants for New and Expanded Services under the Health Center Program (93.527) awarded $12 billion across 4,298 grant awards, an average of $2.8 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Clinica Sierra Vista | California | 3 | $57.7 million |
| Sun River Health, Inc. | New York | 4 | $56.5 million |
| Yakima Valley Farm Workers Clinic | Washington | 3 | $48.6 million |
| Quality of Life Health Services, Inc. | Alabama | 3 | $40.4 million |
| Family Healthcare Network | California | 2 | $39.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-23-027 still open?
No. It closed on December 5, 2022.
Who can apply for Fiscal Year 2023 Quality Improvement Fund – Maternal Health (QIF-MH)?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Fiscal Year 2023 Quality Improvement Fund – Maternal Health (QIF-MH)?
Closed December 5, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $25.0 million in total across about 12 awards.
Who has won Grants for New and Expanded Services under the Health Center Program grants before?
The largest recipients over five fiscal years were Clinica Sierra Vista, Sun River Health, Inc., Yakima Valley Farm Workers Clinic. The program made 4,298 awards worth $12 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)